Investment Banking
Investment Services
Finance

Oppenheimer

$27.42
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Pre-Market
$0.00 (0.00%) Pre-Market

Why Robinhood?

You can buy or sell Oppenheimer and other stocks, options, ETFs, and crypto commission-free!

About

Oppenheimer Holdings, Inc. engages in the provision of financial services. It operates through the following segments: Private Client, Asset Management, Capital Markets, and Corporate/Other. Read More The Private Client segment includes net interest earning on client margin loans and cash balances, money market funds, and stock loan activities. The Asset Management segment consists of investment and fund management services. The Capital Markets segment offers investment banking, fixed income, public finance, and municipal trading. The Corporate/Other segment pertains to legal, compliance, accounting, and internal audit activities. The company was founded in 1881 and is headquartered in New York, NY.

Employees
2,976
Headquarters
New York, New York
Founded
1881
Market Cap
357.60M
Price-Earnings Ratio
13.33
Dividend Yield
1.72
Average Volume
73.12K
High Today
$28.08
Low Today
$27.40
Open Price
$28.08
Volume
6.57K
52 Week High
$34.15
52 Week Low
$23.51

Collections

Investment Banking
Investment Services
Finance
Loan
Banking
US
North America

News

Yahoo Finance23h

From New Treatments To Changing Policies, Industry Leaders Discuss Changing Healthcare Landscape At Oppenheimer & Co. Inc's Annual Conference

NEW YORK, March 19, 2019 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer"), a unit of Oppenheimer Holdings (OPY), will host its 29th Annual Healthcare Conference in New York City on March 19 and 20, 2019. The two-day conference will bring together leading public and private companies across major sectors of the healthcare industry, including Allogene, Caribou, Centene, Cigna, Exelixis, GlaxoSmithKline, HCA, Humana, KSQ Therapeutics, Madrigal, Moderna, Pear Therapeutics, Tandem Diabetes and United Thera...

2
MarketBeatMar 6

Stock Price, News, & Analysis for Oppenheimer

Oppenheimer Holdings Inc., through its subsidiaries, provides middle-market investment bank and full service broker-dealer products and services. The company offers full-service brokerage services covering exchange-traded and over-the-counter corporate equity and debt securities, money market instruments, exchange-traded options and futures contracts, municipal bonds, mutual funds, and unit investment trusts; financial and wealth planning services; and margin lending services. It also provides asset managem...

0
Simply Wall StMar 5

Does Oppenheimer Holdings’s Share Price Gain of 80% Match Its Business Performance?

One simple way to benefit from the stock market is to buy an index fund. But if you pick the right individual stocks, you could make more than that. For example, the Oppenheimer Holdings Inc. (NYSE:OPY) share price is up 80% in the last three years, clearly besting than the market return of around 41% (not including dividends). However, more recent returns haven’t been as impressive as that, with the stock returning just 8.8% in the last year, including dividends. See our latest analysis for Oppenheimer Ho...

0

Earnings

-$0.01
$0.29
$0.59
$0.89
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected Apr 26, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.